Drug Chatter -- Tracking biopharma stock chatter

Profile for Acorda Therapeutics, Inc. (ACOR)

« Back to company index

ACOR Chatter Timeline

Stock Ticker for ACOR

Most Active Tweeters for ACOR

UserTweets
@BioWriterChik 6
@AmericanBanking 5
@OlympiaReport 4
@ZolmaxNews 4
@livetraderalrt 4

Recent Tweets for ACOR

dispatchtribune @dispatchtribune
Investors Buy High Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/BQvCXtpWA0
January 15th 2018, 7:01am
dailypoliticaln @dailypoliticaln
Investors Buy High Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/AXRbkNqFXq
January 15th 2018, 2:01am
WeekHerald @WeekHerald
Acorda Therapeutics $ACOR Cut to “Sell” at Zacks Investment Research https://t.co/3CMhCHoPwy
January 14th 2018, 8:01pm
TribuneTrueBlue @TribuneTrueBlue
Acorda Therapeutics $ACOR Stock Rating Lowered by Zacks Investment Research https://t.co/UHXF9O5T2Z
January 14th 2018, 7:01pm
ZolmaxNews @ZolmaxNews
$ACOR - Zacks Investment Research Lowers Acorda Therapeutics #ACOR to Sell https://t.co/0SnwGHc042
January 14th 2018, 7:01pm
ZolmaxNews @ZolmaxNews
Zacks Investment Research Lowers Acorda Therapeutics $ACOR to Sell https://t.co/UURLQE9svx
January 14th 2018, 6:01pm
WeekHerald @WeekHerald
Zacks Investment Research Lowers Acorda Therapeutics $ACOR to Sell https://t.co/KUjwwllNAD
January 14th 2018, 6:01pm
TheMarketsDaily @TheMarketsDaily
Acorda Therapeutics $ACOR Lowered to Sell at Zacks Investment Research https://t.co/vXFDe01hDQ
January 14th 2018, 6:01pm
MarieSm76375904 @MarieSm76375904
Acorda Therapeutics $ACOR Holder Shanda Payment Holdings LTD Has Boosted Stake https://t.co/nvAYzneLRx
January 14th 2018, 4:01pm
windham_kathryn @windham_kathryn
$0.96 EPS Expected for Acorda Therapeutics, Inc. $ACOR https://t.co/58WxgnMmUL
January 14th 2018, 9:01am
dailypoliticaln @dailypoliticaln
Acorda Therapeutics Sees Unusually High Options Volume $ACOR https://t.co/6RuMt2tHei
January 14th 2018, 4:01am
AmericanBanking @AmericanBanking
Stock Traders Buy Large Volume of Acorda Therapeutics Call Options $ACOR https://t.co/W0Yj1LeXOY #stocks
January 14th 2018, 3:01am
ZolmaxNews @ZolmaxNews
Acorda Therapeutics $ACOR Receives Hold Rating from JPMorgan Chase & Co. https://t.co/fWYadeUvOY
January 13th 2018, 5:01am
ZolmaxNews @ZolmaxNews
Acorda Therapeutics Target of Unusually High Options Trading $ACOR https://t.co/OtCKFonEYI
January 13th 2018, 3:01am
AmericanBanking @AmericanBanking
Traders Buy High Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/kagC0S6Flt #stocks
January 13th 2018, 2:01am
ConsumerFeed @ConsumerFeed
Traders Buy High Volume of Put Options on Acorda Therapeutics $ACOR https://t.co/BAk5pJNrEe
January 13th 2018, 2:01am
dispatchtribune @dispatchtribune
Acorda Therapeutics’ $ACOR “Hold” Rating Reiterated at JPMorgan Chase & Co. https://t.co/rkkSaDlTIx
January 12th 2018, 1:01pm
OlympiaReport @OlympiaReport
Acorda Therapeutics $ACOR Receives “Hold” Rating from JPMorgan Chase & Co. https://t.co/MlOcfVqB3S
January 12th 2018, 1:01pm
WatchlistN @WatchlistN
Analyzing ProQR Therapeutics $PRQR and Acorda Therapeutics $ACOR https://t.co/TEawjX756Y
January 12th 2018, 10:01am
livetraderalrt @livetraderalrt
$ACOR 4.4m ago: SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit… https://t.co/mnL7fn6ucH
January 12th 2018, 8:01am
BioPharmaDive @BioPharmaDive
$ACOR is facing loss of exclusivity for its main product, while $VRX continues to push for a turnaround https://t.co/q8KUGoaXFD #JPM18
January 11th 2018, 4:01pm
DKOptions @DKOptions
$ACOR 1000 July 27 calls bought, a roll from Jan
January 11th 2018, 2:01pm
coleslaw411 @coleslaw411
RT @BioPharmaDive: Day 3 at #JPM18: $VRX and $ACOR make plans, promises of M&A https://t.co/q8KUGoaXFD
January 11th 2018, 1:01pm
BioPharmaDive @BioPharmaDive
Day 3 at #JPM18: $VRX and $ACOR make plans, promises of M&A https://t.co/q8KUGoaXFD
January 11th 2018, 11:01am
TranscriptDaily @TranscriptDaily
Acorda Therapeutics $ACOR Earns Coverage Optimism Score of 0.06 https://t.co/NQwGSlWF80
January 11th 2018, 6:01am
ConsumerFeed @ConsumerFeed
Acorda Therapeutics $ACOR Receives Hold Rating from JPMorgan Chase & Co. https://t.co/JAo4DVWKps
January 11th 2018, 5:01am
wulamkam @wulamkam
$acor cloud break out https://t.co/SFwAhlWWIP
January 10th 2018, 2:01pm
Jake132013 @Jake132013
$ACOR Acorda Therapeutics 24.25 Had 223,381 1 Month Highs. ACOR Last price 24.25 Last change +1.00 +4.30%. https://t.co/pS7zPKSv7b
January 10th 2018, 2:01pm
BioWriterChik @BioWriterChik
In regards to Inbrija Europe talks, $ACOR's @roncohenshair tells me "We are in talks and cannot project when we wou… https://t.co/3Rje1vPPTh
January 10th 2018, 1:01pm
ByMadeleineA @ByMadeleineA
RT @BioWriterChik: $ACOR is in talks to partner Inbrija in Europe but doesn't expect those conversations to pan out before a US approval @r…
January 10th 2018, 1:01pm
BioWriterChik @BioWriterChik
$ACOR is in talks to partner Inbrija in Europe but doesn't expect those conversations to pan out before a US approv… https://t.co/7INh86FNyY
January 10th 2018, 1:01pm
BioWriterChik @BioWriterChik
$ACOR @roncohenshair can't imagine what the FDA would ask at an advisory panel but isn't ruling out the possibility… https://t.co/tmqQGWiV8o
January 10th 2018, 1:01pm
BioWriterChik @BioWriterChik
$ACOR’s @roncohenshair says Refuse to file gave the company a chance to see what the FDA was thinking even before s… https://t.co/6tISfJI2MF
January 10th 2018, 1:01pm
OlympiaReport @OlympiaReport
Acorda Therapeutics $ACOR Lowered to “Sell” at Zacks Investment Research https://t.co/Y5M3yxsQ9y
January 10th 2018, 12:01pm
biotechvalue @biotechvalue
RT @BioWriterChik: $ACOR's @roncohenshair says they expect to lose exclusivity of Ampyra in July (unless their appeal comes through) - sale…
January 10th 2018, 12:01pm
BioWriterChik @BioWriterChik
$ACOR's @roncohenshair says they expect to lose exclusivity of Ampyra in July (unless their appeal comes through) -… https://t.co/sDAU0CYiVg
January 10th 2018, 12:01pm
BioWriterChik @BioWriterChik
$ACOR CEO @roncohenshair calls Refuse to file from FDA a "hiccup" - application was resubmitted in December #JPM18 $JPMHC18
January 10th 2018, 12:01pm
TheMarketsDaily @TheMarketsDaily
Acorda Therapeutics $ACOR Trading Up 11.9% https://t.co/hiiXTAPRUl
January 10th 2018, 8:01am
dispatchtribune @dispatchtribune
Reviewing ProQR Therapeutics $PRQR & Acorda Therapeutics $ACOR https://t.co/oZ7RxwMx0p
January 10th 2018, 8:01am
stockboardinc @stockboardinc
$ACOR FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders of Approaching Deadline in Class Action Laws... - https://t.co/XAyZEm0FPD
January 9th 2018, 3:01pm
MariaDa18810214 @MariaDa18810214
Acorda Therapeutics, Inc. $ACOR Reaches $23.25 After 7.00% Up Move https://t.co/PmTFcNbr27
January 9th 2018, 2:01pm
AmericanBanking @AmericanBanking
Acorda Therapeutics $ACOR Earns Hold Rating from JPMorgan Chase & Co. https://t.co/gKEjwMs55l #stocks
January 9th 2018, 11:01am
ARatings @ARatings
J.P. Morgan Releases a Hold Rating on Acorda Therapeutics $ACOR $JPM https://t.co/erPfxesuvs
January 9th 2018, 9:01am
mariempowers @mariempowers
RT @BioWorld: Ron Cohen, $ACOR: Are we at the tipping point? No, we’re not. I look at it as an arc of progress that accelerates #BTS2018
January 8th 2018, 5:01pm
OlympiaReport @OlympiaReport
Acorda Therapeutics $ACOR Shares Up 11.9% https://t.co/CWeZ7nT6q1
January 8th 2018, 5:01pm
MaisaCorp @MaisaCorp
$ACOR INBRIJA NDA RESUBMITTED IN DECEMBER 2017; INITIAL FDA RESPONSE EXPECTED IN FEBRUARY 2018
January 8th 2018, 4:01pm
SyneosHealth @SyneosHealth
RT @BioWorld: Panel at #BTS18 plenary asks: Is the life sciences sector at a tipping point? Speakers from BIO, $ACOR, $GLYC, JLABS, Syneos…
January 8th 2018, 3:01pm
BioWorld @BioWorld
Ron Cohen, $ACOR: Are we at the tipping point? No, we’re not. I look at it as an arc of progress that accelerates #BTS2018
January 8th 2018, 3:01pm
BioWorld @BioWorld
Panel at #BTS18 plenary asks: Is the life sciences sector at a tipping point? Speakers from BIO, $ACOR, $GLYC, JLABS, Syneos Health
January 8th 2018, 3:01pm
CarlyHFierce @CarlyHFierce
Hard-hit Acorda bows to activist's urging, scouts potential buyers: report https://t.co/trLxMujt2g $ACOR #pharma
January 8th 2018, 2:01pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.